The combination with 10mg bulevirtide dose helps more patients achieve undetectable hepatitis D virus than bulevirtide alone. HealthDay News — The combination of bulevirtide plus peginterferon alfa-2a ...
Weekly peginterferon alfa-2a therapy, with or without daily adefovir, cleared hepatitis D virus (HDV) RNA in about one quarter of patients who participated in the Hep-Net-International Delta Hepatitis ...
Nov. 10, 2003 — The combination of ribavirin with peginterferon-alfa-2a for 22 weeks resulted in a higher sustained virological response (SVR) rate than with peginterferon alone in patients with ...
BURLINGTON, Mass.--(BUSINESS WIRE)--In light of the reported global shortage of Pegasys® (peginterferon alfa-2a), PharmaEssentia (TWSE: 6446), a global biopharmaceutical company, reaffirms its ...
Feb. 7, 2005 -- The European Commission has approved an expanded indication for peginterferon alfa-2a injection, allowing its use in the European Union for the treatment of hepatitis C virus in ...
Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients PEG-IFNα-2a was administered ...
WARMINSTER, Pa., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...